Ranolazine Tablet, Extended Release
Product Images NDC 60290-056

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 60290-056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Umedica Laboratories Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ranolazine-1000mg-60t (Ranolazine 1000mg 60ct)

Ranolazine Extended-Release Tablets 1,000 mg label from Umedica Laboratories USA Inc. The label shows the active ingredient Ranolazine 1,000 mg per extended-release tablet, instructions to swallow tablets whole, and storage conditions of 20° to 25°C. The package contains 60 tablets, manufactured in India and distributed by Umedica Laboratories USA Inc.*

FDA Label Image

Ranolazine-500mg-60t (Ranolazine 500mg 60ct)

Ranolazine Extended-Release Tablets 500 mg label showing oral tablet dosage form, manufactured by Umedica Laboratories Pvt. Ltd., India, and distributed by Umedica Laboratories USA Inc. The package contains 60 tablets and includes storage instructions and a barcode.*

FDA Label Image

Ranolazine-strecture (Ranolazine Structure)

Chemical structure of ranolazine, showing its molecular connectivity and arrangement of atoms relevant to the active ingredient in the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.